Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Nevro Corp (NVRO)
NYSE:NVRO
Holding NVRO?
Track your performance easily
NVRO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.38 - $22.64
Previous Close$5.08
Volume1.04M
Average Volume (3M)511.46K
Market Cap
$189.40M
Enterprise Value$157.99M
Total Cash (Recent Filing)$273.69M
Total Debt (Recent Filing)$242.29M
Price to Earnings (P/E)―
Beta1.78
Next Earnings
Feb 19, 2025EPS Estimate
-$0.68Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.12
Shares Outstanding37,283,164
10 Day Avg. Volume579,301
30 Day Avg. Volume511,459
Standard Deviation0.15
R-Squared0.11
Alpha-0.04
Financial Highlights & Ratios
Price to Book (P/B)0.69
Price to Sales (P/S)0.44
Price to Cash Flow (P/CF)-5.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.37
Enterprise Value/Gross Profit0.54
Enterprise Value/Ebitda-4.26
Forecast
1Y Price Target
$6.10Price Target Upside14.66% Upside
Rating ConsensusModerate Sell
Number of Analyst Covering6
Nevro Corp News
PremiumCompany Announcements
Nevro Corp. Shows Resilience Amidst Revenue ChallengesBulls Say, Bears Say
Bulls Say
Market ExpansionAdding SI Joint and other products could allow for better contracting with larger health systems, expanding NVRO's reach and influence beyond its current market as a single product company.
Product DevelopmentNVRO will announce a product enhancement for iQ, called HFX AdaptiveAI, based on a 100K patient dataset, showcasing its commitment to innovation and patient care.
Strategic ReviewA merger or sale might represent the best strategic action to leverage NVRO's $400M revenue line to drive margin improvement and capitalize on longer-term growth drivers including R&D pipeline and upcoming replacement cycle.
Bears Say
Financial PerformanceNevro missed revenue estimates and lowered its fiscal year outlook, raising concerns about its ability to meet financial targets.
Profitability ChallengesAchieving profitability remains challenging for Nevro without a clear path to revenue growth, especially amid competitive pressures and market softness.
Revenue GrowthNevro's revenue growth is expected to decelerate as physicians evaluate new competitive systems, potentially impacting future financial performance.
---
Ownership Overview
5.25% Insiders
21.96% Mutual Funds
2.74% Other Institutional Investors
58.59% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NVRO FAQ
What was Nevro Corp’s price range in the past 12 months?
Nevro Corp lowest stock price was $4.38 and its highest was $22.64 in the past 12 months.
What is Nevro Corp’s market cap?
Currently, no data Available
When is Nevro Corp’s upcoming earnings report date?
Nevro Corp’s upcoming earnings report date is Feb 19, 2025 which is in 99 days.
How were Nevro Corp’s earnings last quarter?
Nevro Corp released its earnings results on Nov 11, 2024. The company reported -$0.41 earnings per share for the quarter, beating the consensus estimate of -$0.815 by $0.405.
Is Nevro Corp overvalued?
According to Wall Street analysts Nevro Corp’s price is currently Undervalued.
Does Nevro Corp pay dividends?
Nevro Corp does not currently pay dividends.
What is Nevro Corp’s EPS estimate?
Nevro Corp’s EPS estimate is -$0.68.
How many shares outstanding does Nevro Corp have?
Nevro Corp has 37,283,165 shares outstanding.
What happened to Nevro Corp’s price movement after its last earnings report?
Nevro Corp reported an EPS of -$0.41 in its last earnings report, beating expectations of -$0.815. Following the earnings report the stock price went down -44.419%.
Which hedge fund is a major shareholder of Nevro Corp?
Among the largest hedge funds holding Nevro Corp’s share is Engaged Capital LLC. It holds Nevro Corp’s shares valued at 16M.
---
Nevro Corp Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$6.10 (14.66% Upside)
$6.10 (14.66% Upside)
Blogger Sentiment
Bullish
NVRO Sentiment 100%
Sector Average 73%
Sector Average 73%
Hedge Fund Trend
Decreased
By 669.9K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-68.64%
12-Months-Change
Fundamentals
Return on Equity
-27.22%
Trailing 12-Months
Asset Growth
5.94%
Trailing 12-Months
Company Description
Nevro Corp
Nevro Corp. engages in the provision of medical devices. The firm focuses on providing products that improve the quality of life of patients suffering from debilitating chronic pain. It develops and commercializes senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company was founded by Konstantinos Alataris in March 2006 and is headquartered in Redwood City, CA.
---
NVRO Company Deck
---
NVRO Earnings Call
Q2 2024
0:00 / 0:00
---
NVRO Stock 12 Month Forecast
Average Price Target
$6.10
▲(14.66% Upside)
Technical Analysis
Best Analysts Covering NVRO
1 Year
1 Year Success Rate
8/13 ratings generated profit
1 Year Average Return
+29.60%
assigned a sell rating 3 months ago
Copying Adam Maeder's trades and holding each position for 1 Year would result in 61.54% of your transactions generating a profit, with an average return of +29.60% per trade.
---